Skip to Content

← See all GNP Pink Bismuth brands

GNP Pink Bismuth by Amerisource Bergen

Medically reviewed on April 5, 2018

Dosage form: tablet, chewable
Ingredients: BISMUTH SUBSALICYLATE 262mg
Labeler: Amerisource Bergen
NDC Code: 24385-024

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

GNP Pink Bismuth Tablets

Active ingredient (in each tablet)

Bismuth subsalicylate 262 mg

(total salicylate 102 mg per tablet)

Purpose

Upset stomach reliever and anti-diarrheal

uses
  • relieves:
  • diarrhea
  • heartburn
  • indigestion
  • nausea
  • upset stomach associated with these symptoms

Warnings

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. when using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert: Contains salicylate. Do not take if you are

allergic to salicylates (including aspirin)

taking other salicylate products

Do not use if you have
  • bloody or black stools
  • an ulcer
  • a bleeding problem

Ask a doctor before use if you have
  • fever
  • mucus in the stool

Ask a doctor or pharmacist before use if you are
  • taking any drug for anticoagulation (thinning of the blood)
  • diabetes
  • gout
  • arthritis

When using this product

a temporary, but harmless darkening of the stool and/or tongue may occur.

Stop use and ask a doctor if
  • symptoms get worse
  • ringing in the ears or loss of hearing occurs
  • diarrhea lasts more than 2 days

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.

Directions
  • chew or dissolve in mouth
  • adults and children 12 years and over: 2 tablets every 1/2 to 1 hour as needed
  • do not take more than 8 doses (16 tablets) in 24 hours
  • children under 12 years: ask a doctor
  • drink plenty of fluids to help prevent dehydration which may accompany diarrhea.

Other information
  • each tablet contains:sodium less than 1 mg
  • salicylate 102 mg
  • calcium 140 mg
  • very low sodium
  • avoid excessive heat (over 104˚F or 40˚C)
  • TAMPER EVIDENT: Do not use if individual compartments are torn or missing.

Inactive ingredients

calcium carbonate, D&C red 27 aluminum lake, flavor, magnesium stearate, mannitol, pregelatinized starch, saccharin sodium.

PDP

Good Neighbor Pharmacy

Compare to pepto-bismol chewable active ingredient

protective coating

Pink Bismuth

Anti-Diarrheal

Soothing relief for:

upset stomach, indigestion, heartburn, diarrhea & neausea

30 chewable tablets

GNP PINK BISMUTH 
bismuth subsalicylate tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24385-024
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (SALICYLIC ACID) BISMUTH SUBSALICYLATE262 mg
Inactive Ingredients
Ingredient NameStrength
CALCIUM CARBONATE 
D&C RED NO. 27 
MAGNESIUM STEARATE 
MANNITOL 
STARCH, PREGELATINIZED CORN 
SACCHARIN SODIUM 
Product Characteristics
ColorpinkScoreno score
ShapeROUNDSize17mm
FlavorImprint CodeGDC122
Contains    
Packaging
#Item CodePackage Description
1NDC:24385-024-655 BLISTER PACK in 1 CARTON
16 TABLET, CHEWABLE in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33507/07/2011
Labeler - Amerisource Bergen (007914906)
Registrant - Guardian Drug Company (119210276)
Establishment
NameAddressID/FEIOperations
Guardian Drug Company119210276manufacture(24385-024)

 
Amerisource Bergen

← See all GNP Pink Bismuth brands

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide